CrystalForms@Bo 2023, September 10-12
Since 2006 PolyCrystalLine collaborates with the Molecular Crystal Engineering (MCE) group at the Chemistry Department G. Ciamician of the Univer...
Read MoreDCAT 2023, March 20-23
In less than a month we will take off to New York and take part to DCAT (Drug, Chemical & Associated Technologies Association) Week, a great...
Read More
CPhI 2022, November 1-3
Are we going to be present at the next CPhI in Frankfurt? We are, of course! For three days, from November 1st to 3rd, we have the opportunity to reaf...
Read MoreCF@BO 2021, September 10 – 11
ABOUT THE CH@BO n.11 ONLINE CONVENTION Because of the uncertainties still associated with the pandemic of SARS-COVID-19 the 11th edition of the Bologn...
Read More
Des-Methyl-Venlafaxine Salt
New Crystalline Forms of Des-Methyl-Venlafaxine Salt Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a gene...
Read MoreIMAZAMOX: A Quest for Polymorphic Modifications of a Chiral and Racemic Herbicid
ABSTRACT: The structure−property relationships of new polymorphs of the chiral herbicide imazamox were investigated by X-ray diffraction, hot s...
Read More
Join us at CPhI Worldwide – Milan 2021
We invite you to join us at our booth n. 4H93 and learn more about our capabilities: Solid Form Development Crystallization Optimization Analytical Se...
Read MoreMeet us at DCAT in New York!
We invite you to join us in our meeting room at the Intercontinental Suite #510/511 and learn more about our capabilities: Solid Form Development Crys...
Read More
Polymorphs of Dex-Lansoprazole
New Crystalline Forms of Dex-Lansoprazole Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a generic equivalent to Kap...
Read MoreMinodronic Acid Novel Form
PolyCrystalLine discovered a novel crystalline form of Minodronic Acid and filed a patent application. For additional information contact info@po...
Read More